Skip to content
10-K

Annual Report

CHINA JO-JO DRUGSTORES, INC.

0001213900-21-034697

← back to feed
Filed
Jun 29, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Jun 29, 2021 41.75M sh
Shares Diluted FY 2021 · Mar 31, 2021 40.78M sh
Shares Diluted FY 2021 · Mar 31, 2020 32.82M sh
Capex FY 2021 · Mar 31, 2021 $126.77K
Capex FY 2021 · Mar 31, 2020 $656.3K
Operating Cash Flow FY 2021 · Mar 31, 2021 −$62.29K
Operating Cash Flow FY 2021 · Mar 31, 2020 −$6.91M
Long Term Debt FY 2021 · Mar 31, 2021 $1.89M
Long Term Debt FY 2021 · Mar 31, 2020 $4.12M
Short Term Debt FY 2021 · Mar 31, 2021 $762.27K
Short Term Debt FY 2021 · Mar 31, 2020 $1.41M
Cash And Equivalents FY 2021 · Mar 31, 2021 $22.05M
Cash And Equivalents FY 2021 · Mar 31, 2020 $16.18M
Stockholders Equity FY 2021 · Mar 31, 2021 $25.74M
Stockholders Equity FY 2021 · Mar 31, 2020 $20.59M
Current Liabilities FY 2021 · Mar 31, 2021 $64.9M
Current Liabilities FY 2021 · Mar 31, 2020 $57.44M
Total Liabilities FY 2021 · Mar 31, 2021 $81.91M
Total Liabilities FY 2021 · Mar 31, 2020 $80.74M
Current Assets FY 2021 · Mar 31, 2021 $72.23M
Current Assets FY 2021 · Mar 31, 2020 $60.99M
Total Assets FY 2021 · Mar 31, 2021 $106.31M
Total Assets FY 2021 · Mar 31, 2020 $99.52M
Eps Diluted FY 2021 · Mar 31, 2021 −$0.20
Eps Diluted FY 2021 · Mar 31, 2020 −$0.18
Eps Basic FY 2021 · Mar 31, 2021 −$0.20
Eps Basic FY 2021 · Mar 31, 2020 −$0.18
Sga Expense FY 2021 · Mar 31, 2021 $10.9M
Sga Expense FY 2021 · Mar 31, 2020 $8.11M
Net Income FY 2021 · Mar 31, 2021 −$8.12M
Net Income FY 2021 · Mar 31, 2020 −$5.81M
Operating Income FY 2021 · Mar 31, 2021 −$8.84M
Operating Income FY 2021 · Mar 31, 2020 −$7M
Gross Profit FY 2021 · Mar 31, 2021 $29.24M
Gross Profit FY 2021 · Mar 31, 2020 $25.53M
Cost Of Revenue FY 2021 · Mar 31, 2021 $103.89M
Cost Of Revenue FY 2021 · Mar 31, 2020 $91.8M
Revenue FY 2021 · Mar 31, 2021 $133.13M
Revenue FY 2021 · Mar 31, 2020 $117.33M